ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

American Society of Hematology 

1900 M Street, NW, Suite 200

Washington  D.C.  20036  U.S.A.
Phone: 202-776-0544 Fax: 202-776-0545


SEARCH JOBS


Industry
Services






 Company News
Epizyme (EPZM) To Give Oral Presentation On Pre-Clinical Models And Early Clinical Observations Of EZH2 Inhibitor EPZ-6438 At American Society of Hematology Meeting On Lymphoma Biology August 10-13, 2014 6/10/2014 6:25:52 AM
American Society of Hematology Release: Researchers Present Comprehensive "Roadmap" Of Blood Cells 3/27/2014 7:26:47 AM
Neumedicines Inc. Presents HemaMax™ Clinical Data At The American Society of Hematology Conference 12/16/2013 9:26:40 AM
Neumedicines Inc. Presents HemaMax™ Clinical Data At The American Society of Hematology Conference 12/13/2013 7:15:53 AM
Interim Results From Gentium S.p.A.'s Treatment IND For Defibrotide And Additional Data On Defibrotide In The Prevention Of Acute Graft Versus Host Disease (Agvhd) Presented At The American Society of Hematology Annual Meeting 12/11/2013 7:53:03 AM
Celgene International Sárl (CELG) Release: Studies Evaluating REVLIMID® (Lenalidomide) In Lymphoma Presented At American Society of Hematology 12/11/2013 6:37:04 AM
Amgen (AMGN) To Host Post American Society of Hematology Summary Webcast 12/11/2013 6:10:10 AM
Acetylon Pharmaceuticals Presents Data On The Potent Activity Of Ricolinostat (ACY-1215) In Preclinical Models Of Lymphoma At The American Society of Hematology Annual Meeting 12/10/2013 12:04:01 PM
Acetylon Pharmaceuticals Highlights Positive Interim Phase 1b Clinical Data Of Ricolinostat (ACY-1215) In Multiple Myeloma At American Society of Hematology Annual Meeting 12/10/2013 10:18:15 AM
MacroGenics, Inc. (MGNX) Announces Presentation Of Pre-Clinical Data On DART® Molecule Targeting CD123-Positive Leukemic Stem Cells At 55th Annual Meeting Of The American Society of Hematology 12/10/2013 9:38:55 AM
12345678910...